Correlation of abnormal liver function tests in pregnancy with fetomaternal outcome at a tertiary care centre

Kajal Mandal; Shakun Singh

doi:10.18203/2320-1770.ijrcog20262528

Authors

Kajal Mandal Department of Obstetrics and Gynaecology, LLRM Medical College, Meerut, Uttar Pradesh, India
Shakun Singh Department of Obstetrics and Gynaecology, LLRM Medical College, Meerut, Uttar Pradesh, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20262528

Keywords:

Liver function tests, Pregnancy, Fetomaternal outcome, Intrahepatic cholestasis, HELLP syndrome

Abstract

Background: Liver dysfunction during pregnancy is an important cause of maternal and perinatal morbidity. Abnormal liver function tests may indicate pregnancy-specific liver disorders, viral hepatitis, or hepatic involvement in systemic obstetric complications. Early identification is essential for risk stratification and timely management. This study aimed to evaluate the correlation between abnormal liver function tests during pregnancy and fetal-maternal outcomes.

Methods: This prospective observational study was conducted in the Department of Obstetrics and Gynaecology, LLRM Medical College, Meerut, over 18 months. A total of 150 pregnant women with abnormal liver function tests were enrolled after informed consent. Demographic details, obstetric profile, clinical presentation, liver function parameters, viral markers, maternal outcomes, and neonatal outcomes were recorded and analysed.

Results: The mean age of participants was 28.99±3.91 years. Most women were multigravida (88.0%) and unbooked (70.0%). Pruritus was the most common presenting symptom (66.66%), followed by nausea and vomiting (30.66%) and jaundice (18.66%). Mean serum bilirubin was 1.92±3.12 mg/dl, mean aspartate aminotransferase was 196.48±223.96 U/l, and mean alanine aminotransferase was 212.40±249.79 U/l. Cesarean delivery was performed in 41.33% of cases. Postpartum haemorrhage occurred in 43.3%, intensive care unit admission was required in 19.33%, and maternal mortality was 0.66%. Low birth weight occurred in 24.66%, neonatal intensive care unit admission in 40.66%, neonatal jaundice in 26.66%, respiratory distress in 24.66%, and perinatal mortality in 5.33%.

Conclusions: Abnormal liver function tests in pregnancy were associated with significant maternal and neonatal morbidity. Early diagnosis, regular antenatal monitoring, timely referral, and multidisciplinary management are essential for improving feto-maternal outcomes.

Metrics

Metrics Loading ...

References

Bacq Y, Zarka O, Bréchot MC, Mariotte N, Vol S, Tichet J, et al. Liver function tests in normal pregnancy: a prospective study of 103 pregnant women and 103 matched controls. Hepatology. 1996;23(5):1030-4. DOI: https://doi.org/10.1002/hep.510230514

Dajti E, Ravaioli F, Colecchia A, Marasco G, Vestito A, Festi D. Diagnostic approach to elevated liver function tests during pregnancy: a pragmatic narrative review. J Clin Med. 2023;12(15):5018. DOI: https://doi.org/10.3390/jpm13091388

European Association for the Study of the Liver. EASL Clinical Practice Guidelines on the management of liver diseases in pregnancy. J Hepatol. 2023;79(3):768-828. DOI: https://doi.org/10.1016/j.jhep.2023.03.006

Williamson C, Hague WMB. Intrahepatic cholestasis of pregnancy: introduction and overview. Obstet Med. 2024;17(3):169-74. DOI: https://doi.org/10.1177/1753495X241265772

Ovadia C, Seed PT, Sklavounos A, Geenes V, Di Ilio C, Chambers J, et al. Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses. Lancet. 2019;393(10174):899-909. DOI: https://doi.org/10.1016/S0140-6736(18)31877-4

Nana M, Williamson C, Chappell LC, Nelson-Piercy C, Seed PT, Girling J, et al. FIGO guideline on liver disease and pregnancy. Int J Gynaecol Obstet. 2025;169(1):28-59. DOI: https://doi.org/10.1002/ijgo.70161

White A, Ramdhan RC. Acute fatty liver of pregnancy. Gastroenterol Insights. 2024;15(4):851-64. DOI: https://doi.org/10.3390/reprodmed5040025

Singh S, Yadav P, Lal P, Verma P. Role of liver function tests among pregnant women with respect to feto-maternal outcome in third trimester: an analytical cross-sectional study. Int J Reprod Contracept Obstet Gynecol. 2025;14(3):862-8. DOI: https://doi.org/10.18203/2320-1770.ijrcog20250519

Pathak J, Vats S, Sharma N, Gupta S. Comparing feto-maternal outcomes in pregnant women with normal and abnormal liver function tests: a prospective observational study. Cureus. 2024;16(4):e58988. DOI: https://doi.org/10.7759/cureus.56811

Arthuis C, Diguisto C, Lorphelin H, Dochez V, Simon E, Perrotin F, et al. Perinatal outcomes of intrahepatic cholestasis during pregnancy: an 8-year case-control study. PLoS One. 2020;15(2):e0228213. DOI: https://doi.org/10.1371/journal.pone.0228213

Khalid F, Mahendraker N, Tonismae T. HELLP syndrome. In: StatPearls. Treasure Island: StatPearls Publishing; 2023.

Verma D, Saab S, Rahman A, Venkatesan C, Suri V. A systematic approach to pregnancy-specific liver disorders. Gastroenterol Hepatol. 2021;17(9):426-32.

Huang X, Xu J, Liu X, Zhang L, Wang H, Li Y, et al. Evaluating the influence of intrahepatic cholestasis of pregnancy on maternal and neonatal outcomes: a systematic review and meta-analysis. PLoS One. 2024;19(6):e0304604. DOI: https://doi.org/10.1371/journal.pone.0304604